Np mrd loader

Record Information
Version2.0
Created at2024-09-16 04:52:22 UTC
Updated at2024-09-25 11:51:40 UTC
NP-MRD IDNP0341809
Natural Product DOIhttps://doi.org/10.57994/3295
Secondary Accession NumbersNone
Natural Product Identification
Common Nameparaisariamide D
Description It was first documented in 2024 (PMID: 39298800). Based on a literature review a significant number of articles have been published on paraisariamide D (PMID: 39298792) (PMID: 39298763) (PMID: 39298758) (PMID: 39298745).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC42H69N7O7
Average Mass784.0560 Da
Monoisotopic Mass783.52585 Da
IUPAC Name(3S,6S,9S,12S,15R,18R,21R)-9-benzyl-12,15,18-tris[(2S)-butan-2-yl]-1,3,4,10,21-pentamethyl-6-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosane-2,5,8,11,14,17,20-heptone
Traditional Name(3S,6S,9S,12S,15R,18R,21R)-9-benzyl-12,15,18-tris[(2S)-butan-2-yl]-1,3,4,10,21-pentamethyl-6-(2-methylpropyl)-1,4,7,10,13,16,19-heptaazacyclohenicosane-2,5,8,11,14,17,20-heptone
CAS Registry NumberNot Available
SMILES
[H][C@@]1(NC(=O)[C@@H](C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CC=CC=C2)N(C)C(=O)[C@@]([H])(NC(=O)[C@]([H])(NC1=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC
InChI Identifier
InChI=1S/C42H69N7O7/c1-14-25(6)33-38(52)45-34(26(7)15-2)39(53)46-35(27(8)16-3)42(56)49(13)32(23-30-20-18-17-19-21-30)37(51)43-31(22-24(4)5)41(55)48(12)29(10)40(54)47(11)28(9)36(50)44-33/h17-21,24-29,31-35H,14-16,22-23H2,1-13H3,(H,43,51)(H,44,50)(H,45,52)(H,46,53)/t25-,26-,27-,28+,29-,31-,32-,33+,34+,35-/m0/s1
InChI KeyNOIPLVHOJQLSQA-MIXCUGQXSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
HSQC NMR[1H, 13C] NMR Spectrum (2D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
HMBC NMR[1H, 13C] NMR Spectrum (2D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
COSY NMR[1H, 1H] NMR Spectrum (2D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, CDCl3, experimental)rmtehan@utica.eduUtica University, Oregon State UniversityRichard Tehan2024-09-16View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
cascadensis
      Not Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP3.82ChemAxon
pKa (Strongest Acidic)11.87ChemAxon
pKa (Strongest Basic)-2.6ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area177.33 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity214.85 m³·mol⁻¹ChemAxon
Polarizability86.65 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Kwak M Kwak, Succi PJ, Benitez B, Mitchinson CJ, Bergstrom HC: The effects of sex and contraction intensity on fatigability and muscle oxygenation in trained individuals. Appl Physiol Nutr Metab. 2024 Sep 19. doi: 10.1139/apnm-2024-0181. [PubMed:39298792 ]
  2. Bell EC, O'Halloran P, Pazzinatto MF, Wallis JA, Crossley KM, Kemp JL, Perraton Z, Barton CJ: "I feel more confident": a mixed methods evaluation of the influence of Good Life with osteoarthritis Denmark (GLA:D(R)) on physical activity participation, capability, barriers, and facilitators in people with knee osteoarthritis. Braz J Phys Ther. 2024 Sep 5;28(5):101113. doi: 10.1016/j.bjpt.2024.101113. [PubMed:39298800 ]
  3. Weiner LS, Crowley RN, Sheeber LB, Koegler FH, Davis JF, Wells M, Funkhouser CJ, Auerbach RP, Allen NB: Engagement, Acceptability, and Effectiveness of the Self-Care and Coach-Supported Versions of the Vira Digital Behavior Change Platform Among Young Adults at Risk for Depression and Obesity: Pilot Randomized Controlled Trial. JMIR Ment Health. 2024 Sep 19;11:e51366. doi: 10.2196/51366. [PubMed:39298763 ]
  4. Winter JD, Kerns JW, Brandt N, Wastila L, Qato D, Sabo RT, Petterson S, Chung Y, Reves S, Winter C, Winter KM, Elonge E, Ewasiuk C, Fu YH, Funk A, Krist A, Etz R: Prescribing Trends and Associated Outcomes of Antiepileptic Drugs and Other Psychotropic Medications in US Nursing Homes: Proposal for a Mixed Methods Investigation. JMIR Res Protoc. 2024 Sep 19;13:e64446. doi: 10.2196/64446. [PubMed:39298758 ]
  5. Sun B, Zhang W, Zheng M, Meng J, Liu L, Ma G, Yao Q, Wang M: Leaf-like Multiphase Metal Phosphides as Bifunctional Oxygen Electrocatalysts toward Rechargeable Zinc-Air Batteries. Inorg Chem. 2024 Sep 19. doi: 10.1021/acs.inorgchem.4c03022. [PubMed:39298745 ]